序号 |
标题 |
次数 |
作者 |
发布时间 |
75331 |
C18-PEG-NBD,十八烷基-聚乙二醇-苯恶二唑 |
82 |
wyh |
2024-12-13 |
75332 |
Amino-PEG7-C6的组成与结构、化学性质 |
98 |
kx |
2024-12-13 |
75333 |
Ald-CH2-PEG2-CH2CO2 tBu ester(CAS号:2230956-95-1) |
87 |
WYQ |
2024-12-13 |
75334 |
TCO-PEG3-CH2CO2H(CAS号:2249928-25-2) |
77 |
WYQ |
2024-12-13 |
75335 |
C16-sese-mPEG , 棕榈酸双硒键甲氧基聚乙二醇 |
89 |
wyh |
2024-12-13 |
75336 |
DBCO-PEG3-CH2CO-NHS ester,CAS: 2249926-63-2 |
101 |
WYQ |
2024-12-13 |
75337 |
1425485-72-8,DBCO-C6-acid, 11,12-二脱氢-ε-氧代二苯并[b,f]氮杂环辛-5(6H)-己酸 |
82 |
kx |
2024-12-13 |
75338 |
Acid-CH2-PEG3-CH2-t-butyl ester,CAS: 883564-93-0 |
86 |
WYQ |
2024-12-13 |
75339 |
C14-PEG-Biotin ; C14聚乙二醇生物素 |
76 |
wyh |
2024-12-13 |
75340 |
Acid-CH2-PEG5-CH2-t-butyl ester,CAS: 2244684-38-4 |
77 |
WYQ |
2024-12-13 |
75341 |
C14-494 Lipid B4, CAS:2639634-80-1 |
105 |
wyh |
2024-12-13 |
75342 |
Mal-CH2-Cyclohexylcarboxylhydrazide TFA(CAS号:181148-00-5, 359436-59-2) |
89 |
WYQ |
2024-12-13 |
75343 |
Bis-C7-NH2-Thalidomide(hydrochloride),氨基-C7-沙利度胺-C7-氨基盐酸盐 |
77 |
kx |
2024-12-13 |
75344 |
Mal-PEG3-CH2 tBu-ester(CAS号:518044-33-2) |
88 |
WYQ |
2024-12-13 |
75345 |
Mal-PEG3-CH2 NHS ester(CAS号:2230016-26-7) |
91 |
WYQ |
2024-12-13 |
75346 |
氨基-聚乙二醇-棕榈酸,NH2-PEG750-C16 palmitic acid |
92 |
wyh |
2024-12-13 |
75347 |
TCO PEG3 CH2CONHS,CAS: 2249928-26-3 |
76 |
WYQ |
2024-12-13 |
75348 |
Ald-CH2-PEG3-propargyl,CAS: 2249926-66-5 |
83 |
WYQ |
2024-12-13 |
75349 |
Thalidomide-O-C7-acid,2169266-70-8,沙利度胺-O-C7-酸 |
83 |
kx |
2024-12-13 |
75350 |
Ald-CH2-PEG4-propargyl,CAS: 1341156-62-4 |
85 |
WYQ |
2024-12-13 |
75351 |
Ald-benzoylamide-PEG4-CH2 NHS ester(CAS号:2709738-71-4) |
67 |
WYQ |
2024-12-13 |
75352 |
m-PEG10-C11-SH,甲基-十聚乙二醇-C11-巯基 |
66 |
kx |
2024-12-13 |
75353 |
L-Cysteine, S-[[3-(mercaptomethyl)-5-[[[2-[[2-[4,7,10-tris(carboxymethyl) |
96 |
h |
2024-12-13 |
75354 |
Ald-CH2-PEG2-Azide(CAS号:184006-13-1) |
85 |
WYQ |
2024-12-13 |
75355 |
CAS:78063-83-9,Tm-DOTA双功能螯合剂 |
75 |
h |
2024-12-13 |
75356 |
Ald-benzoylamide-PEG2-CH2 NHS ester(CAS号:2253965-05-6) |
72 |
WYQ |
2024-12-13 |
75357 |
m-PEG5-C11-SH,848589-24-2,甲基-五聚乙二醇-C11-巯基 |
66 |
kx |
2024-12-13 |
75358 |
NHS-PEG5000-C16,活性酯聚乙二醇棕榈酸 |
95 |
wyh |
2024-12-13 |
75359 |
CAS:2757339-62-9,DOTA-Tyr-Lys-DOTA |
84 |
h |
2024-12-13 |
75360 |
m-PEG3-C11-SH,594863-55-5,甲基-三聚乙二醇-C11-巯基 |
81 |
kx |
2024-12-13 |
75361 |
Cholesterol-PEG-CY5 CLS-PEG-CY5 |
78 |
wyh |
2024-12-13 |
75362 |
(DOTA-Lys(DOTA))2-Lys-Gly-Gly-Gly-N2H3*TFA |
74 |
h |
2024-12-13 |
75363 |
Pomalidomide-C10-COOH,2428400-33-1,泊马度胺-C10-酸 |
77 |
kx |
2024-12-13 |
75364 |
Ald-benzoylamide-PEG3-CH2 NHS ester,CAS: 2253965-10-3 |
83 |
WYQ |
2024-12-13 |
75365 |
[10-[2-[4-[3-[[4-[[[2-[(2S)-2-Cyano-4,4-difluoro-1-pyrrolidinyl] |
100 |
h |
2024-12-13 |
75366 |
Ald-CH2-PEG2-NHBoc,CAS: 1229024-41-2 |
62 |
WYQ |
2024-12-13 |
75367 |
NH2-PEG1000-C18 Stearic Acid, 氨基-聚乙二醇-硬脂酸 |
63 |
wyh |
2024-12-13 |
75368 |
Pomalidomide-C9-COOH,2243000-24-8,泊马度胺-C9-酸 |
77 |
kx |
2024-12-13 |
75369 |
4-Quinolinecarboxamide, N-[2-[(2S)-2-cyano-1-pyrrolidinyl]-2-oxoethyl]-6-[3-(1-piperazinyl)propoxy]- |
77 |
h |
2024-12-13 |
75370 |
Ald-CH2-PEG3-NHBoc,CAS: 2253965-06-7 |
77 |
WYQ |
2024-12-13 |
75371 |
m-PEG11-(CH2)8-Phosphonic acid,甲基-十一聚乙二醇-C8-膦酸 |
69 |
kx |
2024-12-13 |
75372 |
DOTA-五聚乙二醇-C6-二苯并环辛炔 |
68 |
h |
2024-12-13 |
75373 |
m-PEG3-(CH2)8-Phosphonic acid,2227018-98-4,甲基-三聚乙二醇-C8-膦酸 |
116 |
kx |
2024-12-13 |
75374 |
Ald-CH2-PEG4-NHBoc(CAS号2708026-80-4) |
74 |
WYQ |
2024-12-13 |
75375 |
m-PEG7-(CH2)8-Phosphonic acid,甲基-七聚乙二醇-C8-膦酸 |
82 |
kx |
2024-12-13 |